Persistent Doubts about Reproducibility and Compatability of Data Are Being Overcome One of the hottest research tools these days within the academic, biotech, and pharma communities is DNA ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...

The late 1980s were heady days for molecular biologists. PCR was only a few years old. The automated DNA sequencer had just been invented. The Human Genome Project was being debated in Congress.

Launched in 1990, The Human Genome Project was a monumental effort to sequence and analyze the entire human genome to understand how genetics influence health. While the Human Genome Project helped ...

Dublin, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The "Forensic Technology Market Analysis by Type (PCR, Capillary Electrophoresis, Next-Generation Sequencing, Rapid DNA Analysis, Microarrays), by Services, ...

The prophylactic use of lamivudine can maintain dose-intensity of doxorubicin in hepatitis-B surface antigen (HBs Ag)-positive patients with non-Hodgkin's lymphoma who received cytotoxic chemotherapy ...

Several companies introduced new tools for advancing genomics research at the “55th Annual Meeting of the American Society for Human Genetics,” held recently in Salt Lake City. The offerings are ...

Subclinical acute rejection (SubAR) is a significant risk for kidney transplant recipients, affecting 1 in 4 patients. Early detection of SubAR can help prevent long-term allograft damage, including ...

It has been just over three decades since the first biotechnology company - Genentech - was formed in 1976. Since then biotechnology has become a multi-billion dollar industry with ground-breaking ...